Syra Health | 4: Statement of changes in beneficial ownership of securities-Director Dahlem Andrew
Syra Health | 4: Statement of changes in beneficial ownership of securities-Director Reddy Avutu
Syra Health | 4: Statement of changes in beneficial ownership of securities-Director Paranjape Ketan
Syra Health | 4: Statement of changes in beneficial ownership of securities-Director Reddy Vijayapal
Syra Health | 4: Statement of changes in beneficial ownership of securities-Director Rogers Sherron
Syra Health | 8-K: Current report
Syra Health | 10-Q: Q3 2024 Earnings Report
Syra Health | 8-K: Current report
Syra Health | 8-K: Current report
Syra Health | 4: Statement of changes in beneficial ownership of securities-Officer Prasad Priya
Syra Health | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Prasad Priya
Syra Health | 424B4: Prospectus
Syra Health | EFFECT: Others
Syra Health | CORRESP: CORRESP
Syra Health | 8-K: Current report
Syra Health | S-1: General form for registration of securities under the Securities Act of 1933
Syra Health | 8-K: Syra Health Announces Second Quarter 2024 Financial Results, Led by Strong Revenue Growth of 101% Conference call will be held today, Thursday, August 8 at 9:00 am ET
Syra Health | 10-Q: Q2 2024 Earnings Report
Syra Health | UPLOAD: Others
Syra Health | DRS: Others
No Data
No Data